Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.,Genetics in Medicine

当前位置： X-MOL 学术 › Genet. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Genetics in Medicine ( IF 6.6 ) Pub Date : 2020-01-01 , DOI: 10.1038/s41436-019-0671-2
D Gareth R Evans _{1,

2,

3,

4} , Roope A Kallionpää ₅ , Maurizio Clementi ₆ , Eva Trevisson ₆ , Victor-Felix Mautner ₇ , Sacha J Howell _{1,

4,

8} , Lauren Lewis ₂ , Ouidad Zehou ₉ , Sirkku Peltonen ₁₀ , Antonella Brunello ₁₁ , Elaine F Harkness _{4,

12} , Pierre Wolkenstein ₉ , Juha Peltonen ₅

Affiliation

The Christie NHS Foundation Trust, Manchester, UK.
Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Genesis Breast Cancer Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Institute of Biomedicine, University of Turku, Turku, Finland.
Clinical Genetics Unit, Deparment of Women's and Children's Health, University of Padova, Padova, Italy.
Phacomatoses Department, Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Referral Centre for Neurofibromatoses Dermatology, Hôpital Henri Mondor, APHP, UPEC, Créteil, France.
Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.
Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.